Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
 Disease Category: Rheumatoid Arthritis
Location: United States, MD

Trial Information

A randomized, double-blind, parallel-group study of Cardiovascular safety in Osteoarthritis or Rheumatoid Arthritis patients with or at high risk for Cardiovascular disease comparing Celecoxib with Naproxen and Ibuprofen.

Do you have Rheumatoid Arthritis? You may qualify to participate in a clinical research study.

This is a randomized, double blind, parallel-group study of cardiovascular disease comparing Celecoxib with Naproxen and Ibuprofen. The study is for a 42 week period. The data from this trial will significantly add to our understanding of the cardiovascular safety of nonsteroidal use in our patients.

The Center for Rheumatology and Bone Research
2730 University Blvd West, Suite 306
Wheaton, MD 20902
Phone: 301 942-6610
Fax: 301 942-7833
Email: tbgoldman@arapc.com

View Map

Research Center Information: The Center for Rheumatology and Bone Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.